Adelaida Morte
Barcelona, CT 08038, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Adverse Reactions Following First-Dose Administration of Co-Crystal of Tramadol-Celecoxib Versus Tramadol Alone for Moderate-To-Severe Acute Pain.
Journal: Pain and therapy
Published: December 19, 2024
Safety of Co-Crystal of Tramadol-Celecoxib (CTC) in Patients with Acute Moderate-to-Severe Pain: Pooled Analysis of Three Phase 3 Randomized Trials.
Journal: Pain and therapy
Published: July 10, 2024
Celecoxib-tramadol co-crystal in patients with moderate-to-severe pain following bunionectomy with osteotomy: Secondary analyses by baseline pain intensity and use of rescue medication of a phase 3, randomized, double-blind, factorial, active- and placebo-controlled trial.
Journal: Pain practice : the official journal of World Institute of Pain
Published: July 03, 2024
Efficacy of Co-Crystal of Tramadol-Celecoxib (CTC) in Patients with Acute Moderate-to-Severe Pain: A Pooled Analysis of Data from Two Phase 3 Randomized Clinical Trials.
Journal: Drugs in R&D
Published: May 28, 2024
E-52862-A selective sigma-1 receptor antagonist, in peripheral neuropathic pain: Two randomized, double-blind, phase 2 studies in patients with chronic postsurgical pain and painful diabetic neuropathy.
Journal: European journal of pain (London, England)
Published: April 30, 2024
Co-crystal of tramadol-celecoxib (CTC) for acute moderate-to-severe pain.
Journal: Current medical research and opinion
Published: January 11, 2024
Co-crystal of Tramadol-Celecoxib Versus Tramadol or Placebo for Acute Moderate-to-Severe Pain After Oral Surgery: Randomized, Double-Blind, Phase 3 Trial (STARDOM1).
Journal: Advances in therapy
Published: October 16, 2023
Celecoxib-tramadol co-crystal in patients with moderate-to-severe pain following bunionectomy with osteotomy: A phase 3, randomized, double-blind, factorial, active- and placebo-controlled trial.
Journal: Pain practice : the official journal of World Institute of Pain
Published: June 10, 2022
Comparative Bioavailability Study of a Novel Multi-Day Patch Formulation of Rivastigmine (Twice Weekly) with Exelon® Transdermal Patch (Daily)- A Randomized Clinical Trial.
Journal: Current Alzheimer research
Published: May 13, 2022
Bioavailability Study of a Transdermal Patch Formulation of Rivastigmine Compared with Exelon in Healthy Subjects.
Journal: European journal of drug metabolism and pharmacokinetics
Published: May 05, 2022
Efficacy and safety of co-crystal of tramadol-celecoxib (CTC) in acute moderate-to-severe pain after abdominal hysterectomy: A randomized, double-blind, phase 3 trial (STARDOM2).
Journal: European journal of pain (London, England)
Published: December 08, 2021
Celecoxib-tramadol co-crystal: A Randomized 4-Way Crossover Comparative Bioavailability Study.
Journal: Clinical therapeutics
Published: January 26, 2021
Last Updated: 09/26/2026